U.S. markets closed
  • S&P 500

    4,188.43
    -44.17 (-1.04%)
     
  • Dow 30

    34,742.82
    -34.94 (-0.10%)
     
  • Nasdaq

    13,401.86
    -350.38 (-2.55%)
     
  • Russell 2000

    2,212.70
    -58.93 (-2.59%)
     
  • Crude Oil

    64.86
    -0.06 (-0.09%)
     
  • Gold

    1,836.70
    -0.90 (-0.05%)
     
  • Silver

    27.41
    -0.09 (-0.32%)
     
  • EUR/USD

    1.2140
    +0.0006 (+0.05%)
     
  • 10-Yr Bond

    1.6020
    +0.0250 (+1.59%)
     
  • GBP/USD

    1.4126
    +0.0004 (+0.03%)
     
  • USD/JPY

    108.8200
    -0.0210 (-0.02%)
     
  • BTC-USD

    55,900.03
    -2,282.51 (-3.92%)
     
  • CMC Crypto 200

    1,484.90
    -76.40 (-4.89%)
     
  • FTSE 100

    7,123.68
    -6.03 (-0.08%)
     
  • Nikkei 225

    29,518.34
    +160.52 (+0.55%)
     

U.S. CDC expands COVID-19 vaccine eligibility to 16 and older

·1 min read

April 19 (Reuters) - Everyone in United States aged 16 years and above is now eligible for COVID-19 vaccination, the U.S. Centers for Disease Control and Prevention (CDC) said on Monday. 

  People aged 16 years and above who have underlying medical conditions that increase the risk of serious, life-threatening complications from COVID-19, should be among those offered the vaccine first, according to the U.S. health agency's latest recommendations. (https://bit.ly/3anqDK6) 

  Majority of U.S. states have already expanded their COVID-19 vaccine rollouts to people from this age group. Alaska was the first state to lower statewide eligibility to age 16 and was followed by states including Georgia, Texas and California. 

  Earlier in April, U.S. President Joe Biden had directed states to widen the vaccine eligibility to people aged 18 or above by April 19. No COVID-19 vaccine is authorized yet for those under 16, although testing is underway. 

  More than half of U.S. adults have received at least one COVID-19 vaccine dose, according to CDC. (Reporting by Mrinalika Roy in Bengaluru; Editing by Vinay Dwivedi)